Matches in Wikidata for { <http://www.wikidata.org/entity/Q73586771> ?p ?o ?g. }
Showing items 1 to 46 of
46
with 100 items per page.
- Q73586771 description "artículu científicu espublizáu en xunetu de 1997" @default.
- Q73586771 description "im Juli 1997 veröffentlichter wissenschaftlicher Artikel" @default.
- Q73586771 description "scientific article published on 01 July 1997" @default.
- Q73586771 description "wetenschappelijk artikel" @default.
- Q73586771 description "наукова стаття, опублікована в липні 1997" @default.
- Q73586771 name "A phase I/II study of idarubicin (Ida) with continuous infusion fludarabine (F-ara-A) and cytarabine (ara-C) for refractory or recurrent pediatric acute myeloid leukemia (AML)" @default.
- Q73586771 name "A phase I/II study of idarubicin" @default.
- Q73586771 type Item @default.
- Q73586771 label "A phase I/II study of idarubicin (Ida) with continuous infusion fludarabine (F-ara-A) and cytarabine (ara-C) for refractory or recurrent pediatric acute myeloid leukemia (AML)" @default.
- Q73586771 label "A phase I/II study of idarubicin" @default.
- Q73586771 prefLabel "A phase I/II study of idarubicin (Ida) with continuous infusion fludarabine (F-ara-A) and cytarabine (ara-C) for refractory or recurrent pediatric acute myeloid leukemia (AML)" @default.
- Q73586771 prefLabel "A phase I/II study of idarubicin" @default.
- Q73586771 P1433 Q73586771-DEE261B9-4AC6-4157-9488-F25326B271A0 @default.
- Q73586771 P1476 Q73586771-931E4333-D6BB-4A60-B8C1-B616EBB1709C @default.
- Q73586771 P2093 Q73586771-3F5DF440-68A7-492C-A3CB-A2D81D2499EA @default.
- Q73586771 P2093 Q73586771-7B60042E-9B8A-430F-84A7-98FC2B61792C @default.
- Q73586771 P2093 Q73586771-C5C20757-438A-4D9C-A125-9F2CB8A43028 @default.
- Q73586771 P2093 Q73586771-E4659D95-0EB1-45A5-965D-5426151B77AA @default.
- Q73586771 P304 Q73586771-07401444-A47B-47BA-9D8B-7E8C192EFC04 @default.
- Q73586771 P31 Q73586771-05C76CE1-C701-42ED-AF0D-683B002AB2CA @default.
- Q73586771 P356 Q73586771-0FD11633-6237-4F6A-8224-D8B42327274E @default.
- Q73586771 P433 Q73586771-441D306A-1D87-4354-87BD-F2B1C7CCF432 @default.
- Q73586771 P478 Q73586771-2625A0F6-B8B1-44F7-A6EF-272AAA2A3C52 @default.
- Q73586771 P577 Q73586771-E1CDDA34-51F3-4C19-8685-27C88A8F41B9 @default.
- Q73586771 P698 Q73586771-5C13964A-B526-45B2-B13E-527D9D6B33B0 @default.
- Q73586771 P921 Q73586771-82E099AF-3FA2-447E-9824-4EB7F9C40081 @default.
- Q73586771 P921 Q73586771-97BBD150-FB4C-4D75-B221-164C372734F3 @default.
- Q73586771 P921 Q73586771-AE46C1E3-F6B8-4CEA-9709-744C28354F85 @default.
- Q73586771 P356 00043426-199707000-00007 @default.
- Q73586771 P698 9256828 @default.
- Q73586771 P1433 Q15761808 @default.
- Q73586771 P1476 "A phase I/II study of idarubicin (Ida) with continuous infusion fludarabine (F-ara-A) and cytarabine (ara-C) for refractory or recurrent pediatric acute myeloid leukemia (AML)" @default.
- Q73586771 P2093 "A Leahey" @default.
- Q73586771 P2093 "B Lange" @default.
- Q73586771 P2093 "K Kelly" @default.
- Q73586771 P2093 "L B Rorke" @default.
- Q73586771 P304 "304-308" @default.
- Q73586771 P31 Q13442814 @default.
- Q73586771 P356 "10.1097/00043426-199707000-00007" @default.
- Q73586771 P433 "4" @default.
- Q73586771 P478 "19" @default.
- Q73586771 P577 "1997-07-01T00:00:00Z" @default.
- Q73586771 P698 "9256828" @default.
- Q73586771 P921 Q180983 @default.
- Q73586771 P921 Q264118 @default.
- Q73586771 P921 Q55779816 @default.